ID   MS [Human diffuse large B-cell lymphoma]
AC   CVCL_ZC25
DR   Wikidata; Q98127284
RX   PubMed=16099873;
RX   PubMed=20889926;
RX   PubMed=29416618;
RX   PubMed=29666304;
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
RX   PubMed=16099873; DOI=10.1182/blood-2005-03-1167; PMCID=PMC1895110;
RA   Pham, Lan V.
RA   Tamayo, Archito T.
RA   Yoshimura, Linda C.
RA   Lin-Lee, Yen-Chiu
RA   Ford, Richard Joseph Jr.
RT   "Constitutive NF-kappaB and NFAT activation in aggressive B-cell
RT   lymphomas synergistically activates the CD154 gene and maintains
RT   lymphoma cell survival.";
RL   Blood 106:3940-3947(2005).
//
RX   PubMed=20889926; DOI=10.1182/blood-2010-06-290437; PMCID=PMC3037744;
RA   Pham, Lan V.
RA   Fu, Ling-Chen
RA   Tamayo, Archito T.
RA   Bueso-Ramos, Carlos E.
RA   Drakos, Elias
RA   Vega-Vazquez, Francisco
RA   Medeiros, L. Jeffrey
RA   Ford, Richard Joseph Jr.
RT   "Constitutive BR3 receptor signaling in diffuse, large B-cell
RT   lymphomas stabilizes nuclear factor-kappaB-inducing kinase while
RT   activating both canonical and alternative nuclear factor-kappaB
RT   pathways.";
RL   Blood 117:200-210(2011).
//
RX   PubMed=29416618; DOI=10.18632/oncotarget.20378; PMCID=PMC5787470;
RA   Liu, Wei
RA   Chen, Juan
RA   Tamayo, Archito T.
RA   Ruan, Chang-Geng
RA   Li, Li
RA   Zhou, Shou-Hao
RA   Shen, Chan
RA   Young, Ken H.
RA   Westin, Jason
RA   Davis, Richard E.
RA   Hu, Shi-Min
RA   Medeiros, L. Jeffrey
RA   Ford, Richard Joseph Jr.
RA   Pham, Lan V.
RT   "Preclinical efficacy and biological effects of the oral proteasome
RT   inhibitor ixazomib in diffuse large B-cell lymphoma.";
RL   Oncotarget 9:346-360(2018).
//
RX   PubMed=29666304; DOI=10.1158/1078-0432.CCR-17-3004;
RA   Pham, Lan V.
RA   Huang, Sheng-Jian
RA   Zhang, Hui
RA   Zhang, Jun
RA   Bell, Taylor
RA   Zhou, Shou-Hao
RA   Pogue, Elizabeth
RA   Ding, Zhi-Yong
RA   Lam, Laura
RA   Westin, Jason
RA   Davis, R. Eric
RA   Young, Ken H.
RA   Medeiros, L. Jeffrey
RA   Ford, Richard Joseph Jr.
RA   Nomie, Krystle
RA   Zhang, Leo
RA   Wang, Michael
RT   "Strategic therapeutic targeting to overcome venetoclax resistance in
RT   aggressive B-cell lymphomas.";
RL   Clin. Cancer Res. 24:3967-3980(2018).
//